PS

Pinki Suman

Active Director Director DIN 08106449
DIN 08106449 First appointment Nov 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value •••• Premium profile

About Pinki Suman

Data last updated:

Pinki Suman is a Director at Ambitions Drugs Private Limited (since 2019). The company operates in Trading. Ambitions Drugs Private Limited reported revenue of ₹14 Lakh (FY 2023).

DIN 08106449
Primary Designation Director
Industry Trading
First Appointment 09 Nov 2019
Oldest Company Age 15 yrs
Largest company Ambitions Drugs Private Limited · ₹14 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ambitions Drugs Private Limited U51909DL2011PTC216501
Director09 Nov 20192011₹14 Lakh (FY 2023)Active

Board colleagues of Pinki Suman

NameDINCompanyDesignation
Amod Kumar Suman03457318Ambitions Drugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ambitions Drugs Private Limited
Premium access

Shareholding and investment profile for Pinki Suman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pinki Suman

Pinki Suman currently holds 1 directorship: Ambitions Drugs Private Limited (Director, since 09 Nov 2019, revenue ₹14 Lakh (FY 2023)).

Pinki Suman was first appointed on 09 Nov 2019 as Director at Ambitions Drugs Private Limited.

The current boards of Pinki Suman's companies include Amod Kumar Suman (Ambitions Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available